Urowebinar: New approaches for LUTS management due to BPH

(48:28)

UROwebinar: New treatment options in mCRPC

(1:4:24)

UROWebinar: New technologies in urology, academics and research

(1:56)

UROwebinar: Next generation imaging in renal cancer

(1:5:10)

UROwebinar: New precision medicine opportunities in PC: From molecular understanding to treatment

(1:7:)

UROWebinar: New insights in treatment of bladder cancer From localized to metastatic diseases

(1:1:52)

Urowebinar: New treatments development in NMIBC

(43:50)

UROwebinar: Infections, antimicrobial stewardship and PCa detection: TP vs TRUS prostate biopsy

(1:1:24)

UROWebinar: Male hypogonadism: Testosterone therapy is not dangerous

(1:2:54)

UROwebinar: Paradigm shifts in metastatic hormone sensitive prostate cancer mHSPC Recent treatment

(1:18:13)

UROwebinar: Laser Endoscopic Anatomic Enucleation of Prostate (AEEP)

(1:29:20)

Urowebinar: Prostate cancer update: 2019-2020

(1:7:13)

UROwebinar: Selecting the ideal management for male LUTS

(1:11:20)

Urowebinar: Practical management of bladder cancer

(1:1:32)

UROWebinar: WHO 2022 Classification of Male Genitourinary Tract tumor: What is relevant?

(1:9:13)

UROwebinar: Metastatic prostate cancer

(55:29)

UROwebinar: Update on the EAU ASCO testicular cancer guidelines

(1:19:20)

UROwebinar: New technologies in robotics

(1:2:9)

UROwebinar: Ureteral stenosis and stones: The dog that chases its own tail

(1:11:16)

Urowebinar: Minimally Invasive Treatment for Male LUTS

(1:2:28)

UROwebinar - Learn from the experts

(1:5)

UROwebinar: Renal, bladder and prostate cancer guidelines 2021: From guidelines to real world

(1:5:21)

UROwebinar: Partial nephrectomy: What's new about available approaches?

(1:16:50)

UROWebinar: Benign Prostatic Obstruction BPO: to prolong medical therapy or to move to MIST?

(1:8:22)

UROwebinar: Management of nmCRPC: Putting current evidence into practice

(51:5)

UROwebinar: Adverse events and toxicity management of mPCa patients from an MDT perspective

(58:26)

Urowebinar: MRI as screening test for prostate cancer: New evidences

(54:42)